BindingDB

The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.1M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 698K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Donate Now
Advanced Search

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

15 articles for thisTarget

The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
First-in-Class Selective Inhibitors of the Lysine Acetyltransferase KAT8.EBI
Sapienza University of Rome
Structure-activity relationship and antitumor activity of 1,4-pyrazine-containing inhibitors of histone acetyltransferases P300/CBP.EBI
Baylor College of Medicine
Histone acetyltransferase inhibitors: An overview in synthesis, structure-activity relationship and molecular mechanism.EBI
Sichuan University
Discovery of Acylsulfonohydrazide-Derived Inhibitors of the Lysine Acetyltransferase, KAT6A, as Potent Senescence-Inducing Anti-Cancer Agents.EBI
Monash University (Parkville Campus)
Discovery of Benzoylsulfonohydrazides as Potent Inhibitors of the Histone Acetyltransferase KAT6A.EBI
Cancer Therapeutics Crc
Discovery, Structure-Activity Relationship, and Biological Activity of Histone-Competitive Inhibitors of Histone Acetyltransferases P300/CBP.EBI
Avera Institute For Human Genetics
Cyclopropyl Fused Thiazin-2-Amine Compounds as Beta-Secretase Inhibitors and Methods of UseBDB
Amgen
Substituted heterocycles as aldehyde dehydrogenase inhibitorsBDB
Kayothera
ERAP INHIBITORSBDB
Universite De Lille
Isoquinolin-3-yl carboxamides and preparation and use thereofBDB
Biosplice Therapeutics
Mu opioid receptor modulatorsBDB
University of California
2,3-dihydrofuro[2,3-b]pyridine compoundsBDB
Eli Lilly
Selective inhibitors of protein arginine methyltransferase 5 (PRMT5)BDB
Prelude Therapeutics
Benzenesulfonamide compounds and their use as therapeutic agentsBDB
Xenon Pharmaceuticals
Methylamine derivatives as lysysl oxidase inhibitors for the treatment of cancerBDB
The Institute of Cancer Research: Royal Cancer Hospital